BSR and BHPR guideline for the treatment of axial spondyloarthritis (including ankylosing spondylitis) with biologics

Source:
British Society for Rheumatology - BSR
Publisher:
British Society for Rheumatology (BSR)
Publication date:
01 August 2016

Abstract

These guidelines provide evidence-based guidance for UK clinicians prescribing biologics for adult patients with axSpA. This includes the criteria for starting treatment, the choice of drug and assessing response to treatment.